Pentraxin 3 as a Prognostic Biomarker in Patients with Systemic Inflammation or Infection

張睆婷（2014）。The role of Pentraxin 3 in human cervical cancer cells〔碩士論文，中山醫學大學〕。華藝線上圖書館。https://doi.org/10.6834/CSMU.2014.00069
Gulacti, U., Lok, U., Aydin, I., Turgut, K., Yavuz, E., Kaya, H., Kafadar, H., Arslan, E., Sonmez, C., Algin, A., Kurt, E., Ozdin, M., & Yucetas, S. C. (2023). Clinical Value of Inflammatory Biomarkers in Determining Severity of COVID-19. Journal of Acute Medicine, 13(2), 58-64. https://doi.org/10.6705/j.jacme.202306_13(2).0002
Ogata, A., Kumanogoh, A., & Tanaka, T. (2012). Pathological Role of Interleukin-6 in Psoriatic Arthritis. Arthritis, 2012(), 181-186. https://doi.org/10.1155/2012/713618
Yeh, M. H., & Tsai, T. F. (2007). Clinical Analysis of Psoriatic Inpatients-A 10-year Retrospective Study. 中華皮膚科醫學雜誌, 25(2), 103-111. https://doi.org/10.29784/DS.200706.0003
Igari, K., Kudo, T., Toyofuku, T., & Inoue, Y. (2016). Relationship of Inflammatory Biomarkers with Severity of Peripheral Arterial Disease. International Journal of Vascular Medicine, 2016(), 112-117. https://doi.org/10.1155/2016/6015701